Skip to main content
. 2014 Jul-Sep;6(3):224–230. doi: 10.4103/0974-7796.134275

Figure 1.

Figure 1

Detection of lymphatics by D2-40 immunostaining in prostate carcinoma (a-b). Note peritumoral lymphatic invasion (B, arrows). Limited LYVE-1 expression in prostate cancer (c-d). Note invasion of lymphatic vessel by tumor in D (arrow). Immunostaining for VEGF-C in prostate carcinoma (e–f). Strong cytoplasmic staining was present in the tumor cells, with extremely limited staining in the stroma and BPH cells (e). All microphotographs ×200 magnification